CAR-T Cell Therapy: Clinical Trials

5 trials for CAR-T Cell Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 not yet recruiting, 1 unknown. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Recruiting 3, Not yet recruiting 1, Unknown 1

Follow CAR-T Cell Therapy: new trials by email Literature Review of CAR-T Cell Therapy trials Research Report on CAR-T Cell Therapy

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL
AntiCD19 CAR-T combined with BTKi in the treatment of newly diagnosed high-risk CLL/SLL patients - CLL, CAR-T Cell Therapy
Not applicableRecruitingThe Affiliated Hospital of Xuzhou Medical University502025-09-012025-08-13
Nutrition OUtReach In Systems of Healthcare
Food Bags - ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Autologous Haemopoietic Stem Cell Transplant
Not applicableRecruitingUniversity of Kansas Medical Center2102025-05-012026-04-20
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma
Axicabtagene Ciloleucel - CAR-T Cell Therapy, High-risk Large B-cell Lymphoma (LBCL)
Not applicableNot yet recruitingRuijin Hospital602025-04-302025-04-22
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
Step Up, Usual Care Plus (UC+) - Hematopoietic Stem Cell Transplant, CAR-T Cell Therapy
Not applicableRecruitingDuke University1772025-04-212026-07-15
CAR T-CELL Therapy Educational Video Trial
Educational Video Tool - Hematologic Malignancy, CAR-T Cell Therapy
Not applicableUnknownMassachusetts General Hospital802020-05-252023-01-26

Narrower conditions

Hematologic Neoplasms (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

axicabtagene ciloleucel (1)

Sponsors

Duke University (1)  ·  Massachusetts General Hospital (1)  ·  Ruijin Hospital (1)  ·  The Affiliated Hospital of Xuzhou Medical University (1)  ·  University of Kansas Medical Center (1)

Countries

United States (3)  ·  China (2)

Top investigators

Anthony Sung, MD (1)  ·  Patrick C Johnson, MD (1)

NIH funding

R01NR021468 (1)